Viking Therapeutics (VKTX) Q2 2024 Earnings
VKTX·Reported July 24, 2024·After market close
Diluted EPS came in at $-0.20, beat the $-0.26 consensus by $0.06.
Diluted EPS
$-0.20beat by $0.06
Consensus: $-0.26
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Viking Therapeutics's Q2 2024 earnings report.
Viking Therapeutics (VKTX) reported Q2 2024 earnings on July 24, 2024 after market close.
Viking Therapeutics reported diluted EPS of $-0.20 for Q2 2024.
EPS beat the consensus estimate of $-0.26 by $0.06.
You can read the 10-Q periodic report (0000950170-24-086111) directly on SEC EDGAR. The filing index links above go to sec.gov.